The pathophysiological basis of the protective effects of metformin in heart failure

The pathophysiological basis of the protective effects of metformin in heart failure

Metformin, currently recommended as the drug of first choice in type 2 diabetes mellitus (T2DM), is one of the few antihiperglycemic drugs to reduce cardiovascular risk. Nonetheless, due to the risk of lactic acidosis during metformin therapy, its usage in patients with diabetes and heart failure (H...

Full description

Bibliographic Details
Main Authors:	Aleksandra Dziubak, Grażyna Wójcicka
Format:	Article
Language:	English
Published:	Index Copernicus International S.A. 2017-08-01
Series:	Postępy Higieny i Medycyny Doświadczalnej
Subjects:	metformina niewydolność serca kinaza białkowa aktywowana AMP metformin Heart Failure AMP-activated protein kinase
Online Access:	http://phmd.pl/gicid/01.3001.0010.3855

Similar Items

Metformina – mechanizmy działania i zastosowanie w terapii cukrzycy typu 2[i][/i]
by: Marzena Grzybowska, et al.
Published: (2011-01-01)

The involvement of galectin-3 in heart failure
by: Maria Kałan, et al.
Published: (2015-09-01)

Jakość życia chorych z niewydolnością serca = Quality of life in patients with heart failure
by: Beata Kowalczyk, et al.
Published: (2016-10-01)

Rola komunikacji lekarz-pacjent w przewlekłej niewydolności serca = The role of communication doctor-patient in chronic heart failure
by: Łukasz Wołowiec, et al.
Published: (2015-04-01)

Niewydolność serca - definicja, klasyfikacja, epidemiologia, objawy i leczenie = Heart failure - definition, classification, epidemiology, symptoms and treatment
by: Beata Kowalczyk, et al.
Published: (2017-02-01)

Role of hypothalamic AMP-activated protein kinase in the control of food intake
by: Franciszek Fijałkowski, et al.
Published: (2010-05-01)

Ocena skuteczności i bezpieczeństwa farmakoterapii inhibitorami aldosteronu w niewydolności serca = Evaluation of the efficacy and safety of pharmacotherapy using aldosterone antagonists in heart failure
by: Agata Tarczykowska, et al.
Published: (2015-07-01)

Future of Metformin Administration in Sepsis Management
by: Mojtaba Mojtahedzadeh, et al.
Published: (2017-02-01)

Metabolic Effects of Metformin in the Failing Heart
by: Aleksandra Dziubak, et al.
Published: (2018-09-01)

Pozawałowa niewydolność serca – optymalne leczenie według współczesnych standardów – opis przypadku
by: Anna Kaźmierczak-Dziuk
Published: (2011-10-01)

Ocena wartości rokowniczej osoczowego stężenia białka C-reaktywnego oznaczonego metodą o wysokiej czułości (hs-CRP) u chorych z przewlekłą niewydolnością serca = Usefulness of serum high-sensitivity C-reactive protein (hs-CRP) level as prognostic factor in patients with chronic heart failure
by: Daniel Rogowicz, et al.
Published: (2016-07-01)

The effect of metformin-induced AMPK activation on adipogenesis and HIV replication
by: Alexandre, Kabamba Bankoledi
Published: (2008)

Przydatność rokownicza nowych markerów w przewlekłej skurczowej niewydolności serca = The prognostic usefulness of new markers in chronic systolic heart failure
by: Agnieszka Surowiec, et al.
Published: (2015-08-01)

Effect of metformin on semen quality
by: Saleem Ali Banihani

Therapeutic Applications of Type 2 Diabetes Mellitus Drug Metformin in Patients with Osteoarthritis
by: Parkyong Song, et al.
Published: (2021-02-01)

Metformin inhibits the development and metastasis of colorectal cancer
by: Hasegawa, H., et al.
Published: (2022)

Metformin in patients with ischemic heart disease and type 2 diabetes mellitus: mechanism of action and clinical efficiency
by: Ekaterina Nikodimovna Kravchuk, et al.
Published: (2013-03-01)

Metformin as an energy restriction mimetic agent for breast cancer prevention
by: Zongjian Zhu, et al.
Published: (2011-01-01)

A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan
by: Ibrahim Mohammed, et al.
Published: (2021-08-01)

Metformin Mitigates Cartilage Degradation by Activating AMPK/SIRT1-Mediated Autophagy in a Mouse Osteoarthritis Model
by: Chenzhong Wang, et al.
Published: (2020-07-01)

Metformin Alleviates Lipopolysaccharide-induced Acute Lung Injury through Suppressing Toll-like Receptor 4 Signaling
by: Haleh Vaez, et al.
Published: (2017-12-01)

Metformin Increases Sarcolemma Integrity and Ameliorates Neuromuscular Deficits in a Murine Model of Duchenne Muscular Dystrophy
by: Xia Dong, et al.
Published: (2021-05-01)

Evidence for acute activation of 5'-AMP-activated protein kinase by metformin and salicylate in rat skeletal muscles
by: Oshima, Rieko
Published: (2015)

Acidosis láctica grave asociada a intoxicación por metformina Severe lactic acidosis associated to metformin intoxication
by: M. S. Holanda Peña, et al.
Published: (2007-02-01)

Metformin, an AMPK Activator, Inhibits Activation of FLSs but Promotes HAPLN1 Secretion
by: Yong Chen, et al.
Published: (2020-06-01)

Metformin improves salivary gland inflammation and hypofunction in murine Sjögren’s syndrome
by: Ji-Won Kim, et al.
Published: (2019-06-01)

Metformin Induces Different Responses in Clear Cell Renal Cell Carcinoma Caki Cell Lines
by: Mazhar Pasha, et al.
Published: (2019-03-01)

Formulation of a modified release metformin. HCl matrix tablet: influence of some hydrophilic polymers on release rate and in-vitro evaluation
by: John Rojas, et al.
Published: (2011-09-01)

Respostas fisiológicas ao exercício agudo em ratos obesos tratados com metformina Physiological responses to intense exercise in obese rats treated with metformin
by: Gustavo Gomes de Araujo, et al.
Published: (2007-12-01)

Metformin in heart failure patients
by: Abdulhalim Jamal Kinsara, et al.
Published: (2018-01-01)

The Eeffect of Metformin Combined with Calcium-Vitamin D3 Against Diet-Induced Nonalcoholic Fatty Liver Disease
by: Sara Shojaei Zarghani, et al.
Published: (2018-03-01)

How treatments with endocrine and metabolic drugs influence pituitary cell function
by: Giovanni Tulipano
Published: (2020-02-01)

Molecular Basis for Ser/Thr Specificity in PKA Signaling
by: Matthias J. Knape, et al.
Published: (2020-06-01)

Metformina interage com o treinamento físico diminuindo a glicemia e aumentando o armazenamento de glicogênio em ratos diabéticos Metformin interacts with physical training decreasing glycemia and increasing glycogen supply in diabetic rats
by: Eunice da Silva-Costa, et al.
Published: (2008-08-01)

Metformin Potentiates the Effects of Anlotinib in NSCLC via AMPK/mTOR and ROS-Mediated Signaling Pathways
by: Zhongling Zhu, et al.
Published: (2021-08-01)

SREBP-2, a new target of metformin?
by: Zhang F, et al.
Published: (2018-12-01)

Mózg i cytokiny – wspólne podłoże depresji, otyłości i chorób układu krążenia?
by: Marcin Ufnal, et al.
Published: (2011-01-01)

ATP-induced inflammasome activation and pyroptosis is regulated by AMP-activated protein kinase in macrophages
by: Qing-Bing Zha, et al.
Published: (2016-12-01)

Vav3, a GEF for RhoA, Plays a Critical Role under High Glucose Conditions
by: Jie Sha, et al.
Published: (2014-09-01)

AMPK as a Novel Target for Treatment of Neuropathic and Post-Surgical Pain
by: Tillu, Dipti Vilas
Published: (2014)

Cannot write session to /tmp/vufind_sessions/sess_t2hvv5v5cl3ddhdmjravtmr5c4